Tesar V
I. interní klinika 1. LF UK a VFN, Praha.
Cas Lek Cesk. 1998 Jul 13;137(14):438-41.
Hypertension is found in more than 80% of patients with terminal chronic renal failure. Its etiology is multifactorial, however sodium and fluid retention are decisive. The basic treatment involves attainment and maintenance of optimal "dry weight". Antihypertensive treatment is necessary in only roughly 30% patients. Hypertension after renal transplantation is most frequently associated with immunosuppressive treatment (steroids, cyclosporin), however, it is important to consider also the role played by chronic graft rejection and rule out stenosis of the graft artery. Severe hypertension complicates also some types of acute renal failure, while malignant hypertension may be its cause.
超过80%的终末期慢性肾衰竭患者存在高血压。其病因是多因素的,然而钠和液体潴留起决定性作用。基本治疗包括达到并维持最佳“干体重”。仅约30%的患者需要进行抗高血压治疗。肾移植后的高血压最常与免疫抑制治疗(类固醇、环孢素)相关,然而,也必须考虑慢性移植排斥反应所起的作用,并排除移植肾动脉狭窄。严重高血压也会使某些类型的急性肾衰竭复杂化,而恶性高血压可能是其病因。